<DOC>
	<DOC>NCT01216033</DOC>
	<brief_summary>The aim is to study if breast cancer metastases accumulate the newly developed HER2 binding molecule 111-In-ABY025 and if that shows whether the metastases express HER2.</brief_summary>
	<brief_title>Exploratory Study of Breast Cancer With ABY025</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>female age &gt;20 years one or more known metastases localizations other critical disease than breast cancer age â‰¤ 20 years</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Breast cancer</keyword>
	<keyword>Diagnostics</keyword>
	<keyword>HER2</keyword>
	<keyword>Imaging</keyword>
	<keyword>Metastases</keyword>
	<keyword>SPECT</keyword>
	<keyword>Imaging of metastases</keyword>
</DOC>